Literature DB >> 11812560

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.

E P Quinlivan, J McPartlin, H McNulty, M Ward, J J Strain, D G Weir, J M Scott.   

Abstract

Fortification of food with folic acid to prevent neural-tube defects in babies also lowers plasma total homocysteine, which is a risk factor for vascular disease. We investigated the effect of folate and vitamin B12 on homocysteine concentrations. 30 men and 23 women received sequential supplementation with increasing doses of folic acid. After supplementation, the usual dependency of homocysteine on folate diminished, and vitamin B12 became the main determinant of plasma homocysteine concentration. This finding suggests that a fortification policy based on folic acid and vitamin B12, rather than folic acid alone, is likely to be much more effective at lowering of homocysteine concentrations, with potential benefits for reduction of risk of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812560     DOI: 10.1016/s0140-6736(02)07439-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Brandilyn A Peters; Megan N Hall; Xinhua Liu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad Nasir Uddin; Tariqul Islam; Vesna Ilievski; Joseph H Graziano; Mary V Gamble
Journal:  J Nutr       Date:  2015-08-26       Impact factor: 4.798

2.  Serum homocysteine and folate concentrations among a US cohort of adolescents before and after folic acid fortification.

Authors:  Daniel A Enquobahrie; Henry A Feldman; Deanna H Hoelscher; Lyn M Steffen; Larry S Webber; Michelle M Zive; Eric B Rimm; Meir J Stampfer; Stavroula K Osganian
Journal:  Public Health Nutr       Date:  2012-10       Impact factor: 4.022

Review 3.  Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

4.  Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy.

Authors:  Birol Ozer; Ender Serin; Yuksel Gumurdulu; Fazilet Kayaselcuk; Ruksan Anarat; Gurden Gur; Kemal Kul; Mustafa Guclu; Sedat Boyacioglu
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products.

Authors:  Julie Robertson; Francesco Iemolo; Sally P Stabler; Robert H Allen; J David Spence
Journal:  CMAJ       Date:  2005-06-07       Impact factor: 8.262

6.  Association of recreational physical activity with homocysteine, folate and lipid markers in young women.

Authors:  Manuela Di Santolo; Giuseppe Banfi; Giuliana Stel; Sabina Cauci
Journal:  Eur J Appl Physiol       Date:  2008-10-14       Impact factor: 3.078

Review 7.  Vitamin B12 and health.

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2008-04       Impact factor: 3.275

8.  Homocysteine concentration, related B vitamins, and betaine in pregnant women recruited to the Seychelles Child Development Study.

Authors:  Julie Mw Wallace; Maxine P Bonham; Jj Strain; Emeir M Duffy; Paula J Robson; Mary Ward; Helene McNulty; Philip W Davidson; Gary J Myers; Conrad F Shamlaye; Tom W Clarkson; Anne M Molloy; John M Scott; Per M Ueland
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

9.  The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies.

Authors:  Natalie J Colson; Helen L Naug; Elham Nikbakht; Ping Zhang; Joanna McCormack
Journal:  Eur J Nutr       Date:  2015-10-23       Impact factor: 5.614

Review 10.  Relationship of homocysteine with cardiovascular disease and blood pressure.

Authors:  Rajani Dinavahi; Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.